• Proteins In The Blood Hint At Biological Basis Of Long COVID

    Clinical Research News | A point-of-care (POC) diagnostic test for long COVID is under development that would be a godsend to the millions of Americans still suffering the health consequences of SARS-CoV-2 months after being infected.

    Aug 11, 2023

  • Ramita Tandon and How Walgreens Is Tackling Disparities in Clinical Trials

    Clinical Research News | The COVID-19 pandemic amplified a lot of existing weaknesses in the healthcare system, and clinical research was no exception: less than 5% of the nation partakes in clinical trials and 75% of those participants are white. This disparity indicates that drugs undergoing clinical trials don’t necessarily have the same effect on the rest of the American population, particularly those from ethnic and racial minority groups.

    Aug 8, 2023

  • Three Keys to Improving Diversity in Clinical Trials

    Clinical Research News | Clinical research should be a viable option for everyone who wishes to participate. Sponsors know that diverse trials lead to stronger data and better drugs, yet there are many obstacles to recruiting and retaining diverse participants – from distrust, to lack of access, to financial and logistical barriers.

    Aug 4, 2023

  • Researchers Close In On Protein Panel For Predicting Islet Autoimmunity

    Clinical Research News | A team of researchers from North America and Europe have identified a panel of 83 markers in the blood of children genetically predisposed to develop type 1 diabetes that looks promising as a predictor of which individuals will progress to islet autoimmunity six months prior to its onset.

    Aug 3, 2023

  • Mitigating Tactics To Improve The Generalizability Of Pragmatic Trials

    Clinical Research News | Randomized controlled trials are a fantastic first step in assessing the clinical effects of medical interventions, but they are not sufficient to transform the “busy throughput environment” of real-world healthcare involving appointment scheduling and referrals, differing practice patterns, and patients with comorbidities and social determinants of health like housing instability and low literacy skills.

    Aug 1, 2023

  • Crowd-Sourced Neuroscience, New Sickle Cell Dataset Published, FDA-Approved Software

    Clinical Research News | Researchers from around the world are invited to publicly design a shared brain experiment that will run on the Allen Brain Observatory, Angry@Arthritis has announced the first global osteoarthritis clinical trial locator, Indiana Sickle Cell Data Collection program published a paper on persons living with the disease in the state, and Boston Scientific received FDA approval to new software. Plus, new product updates and partnerships from Arrayjet, Critical Path Institute, Clinisys, and more.

    Jul 27, 2023

  • Follow the Money: AI Platform for Acute Immune States, Acquisitions, Expanding Solutions Portfolio

    Clinical Research News | AI platform used for acute immune states, acquisitions, solutions portfolio expansion, and more.

    Jul 26, 2023

  • The Role of Digital Transformation in Patient Engagement, Recruitment, & Retention

    Clinical Research News | Researchers at the Laureate Institute for Brain Research (Tulsa, Oklahoma) are repurposing a vibrating capsule that is FDA-cleared for treating chronic constipation to study how people sense the hidden signals originating in their gastrointestinal (GI) system.

    Jul 21, 2023

  • Vibrating Capsule Repurposed For Assessment of ‘Visceral Acuity’

    Clinical Research News | Researchers at the Laureate Institute for Brain Research (Tulsa, Oklahoma) are repurposing a vibrating capsule that is FDA-cleared for treating chronic constipation to study how people sense the hidden signals originating in their gastrointestinal (GI) system.

    Jul 19, 2023

  • Custom-Designed Vaccines Look Promising For Treating Melanoma

    Clinical Research News | Messenger RNA (mRNA) vaccines “personalized” to the genetics of a tumor look promising for improving the treatment of melanomas, based on results of a phase 2 clinical trial recently presented at the American Society of Oncology congress in Chicago.

    Jul 18, 2023

  • CROs Leading The Way In Modern-Day Clinical Data Management

    Clinical Research News | Contract research organizations (CROs) increasingly find themselves on the leading edge of changes afoot in clinical data management, making it less about the policing of information and more about extracting meaningful insights from it.

    Jul 13, 2023

  • Murray Aitken on Advancing Diversity in Clinical Development

    Clinical Research News | Diversity in clinical trials plays a key role in determining the effectiveness of new medications and treatments. However, clinical trials have proven that participant pools are not as diverse as they should be.

    Jul 11, 2023

  • Time Is Now To Take A Hard Look At Decentralized Trials

    Clinical Research News | Many assumptions have been made about how decentralized clinical trials (DCTs) could help with clinical trial diversity although little “rigorous evidence” exists regarding actual effects on study enrollment.

    Jul 6, 2023

  • Walgreens, Freenome Team Up, New AI Products from ObjectiveHealth, Saama, More

    Clinical Research News | Walgreens and Freenome team up to advance clinical studies; ObjectiveHealth announces new AI tool to optimize clinical trial performance; Saama deploys AI solutions to automate key clinical development processes; American Gene Technologies launch new company that solely focuses on HIV cure research; and more.

    Jun 29, 2023

  • Budget Proposals For Industry-Sponsored Pediatric Trials Need Renegotiating

    Clinical Research News | Many sites engaged in industry-sponsored pediatric clinical trials are struggling to make them monetarily feasible because sponsors often apply the same budget figures used for adult trials and sites may be unaccustomed to talking about line-item costs for different procedures.

    Jun 28, 2023

  • Follow the Money: AI Drug Treatments, Stocks, Quantum Metabolic Polarizers, More

    Clinical Research News | Leveraging AI for drug treatments, stock investments, revolutionizing metabolic MRIs with polarizers, and more.

    Jun 27, 2023

  • Success in Simplicity: Complex Clinical Trials and the eCOA Systems That Support Them

    Clinical Research News | It’s no coincidence that clinical trials are becoming more complex. Advancements in technology are enabling sponsors, clinicians, and trial teams to gather more information than ever before. However, the latest “bells and whistles” can add complexity to trials and distract trial teams from their main focus: collecting data to advance therapies for very ill patients who need them most.

    Jun 23, 2023

  • Biologics, Anti-Inflammatory Drugs Current Focus Of Alzheimer’s Disease Trials

    Clinical Research News | The latest report on clinical trials in the Alzheimer’s drug development pipeline points to the growing potential of anti-amyloid monoclonal antibodies for treating the brain-robbing condition. Anti-inflammatory agents comprise the single largest therapeutic category with 25 drugs, but astoundingly no two are aimed at the same target.

    Jun 21, 2023

  • Rescuing a Study in Jeopardy with Comprehensive Clinical Adjudication

    Clinical Research News | Global clinical trial programs are complex, often encompassing dozens of studies for increasingly uncommon indications. Sponsors of these programs are wisely seeking out independent adjudication of clinical events, or endpoints, that occur over the course of the trial to ensure patient safety and the efficacy of drugs and devices. While endpoint adjudication is not required by regulatory bodies, it can deliver valuable insights during a trial and lend strong, unbiased support for approvals down the road.

    Jun 16, 2023

  • N-Lorem Foundation Bringing Real Hope To ‘N-Of-1’ Patients

    Clinical Research News | Stanley T. Crooke, M.D., Ph.D., founder and longtime leader of the company that pioneered RNA-targeted therapeutics, is now chairman and CEO of the n-Lorem Foundation descaling the technology to treat patients helpless before a healthcare system that wasn’t built for “n-of-1” problems. He will be addressing a room of physicians and scientists tomorrow on the campus of Vanderbilt University.

    Jun 14, 2023